Evaluating Natalizumab's Risk-Benefit Profile in MS

Описание к видео Evaluating Natalizumab's Risk-Benefit Profile in MS

Both experts review the effectiveness of natalizumab against its safety profile in multiple sclerosis given past experience and clinical trial data.

Комментарии

Информация по комментариям в разработке